Opening Remarks
>Prof. Dr. Ali Demir SEZER, Marmara University Faculty of Pharmaceuticals
>Prof. Dr. Ümit KERVAN, TÜSEB President
>Hüseyin ÇELİK*, TİTCK President
Akdeniz Hall (Hall 2)
The Pharmaceutical Technologies and API Symposium brings together academia, public institutions, and industry to address the full value chain of pharmaceuticals, from R&D to manufacturing, through a multidisciplinary perspective encompassing biotechnology, artificial intelligence, GMP processes, and clinical research, fostering knowledge exchange and collaboration.
Following the opening remarks, the session will address regulatory perspectives on GMP Guide Annex 22 and artificial intelligence applications; subsequently, the journey of biotechnological drugs from R&D to production will be comprehensively explored, with expert insights on biosimilars, clinical exemptions, and domestic manufacturing strategies.
* This session will be conducted online.
>Prof. Dr. Ali Demir SEZER, Marmara University Faculty of Pharmaceuticals
>Prof. Dr. Ümit KERVAN, TÜSEB President
>Hüseyin ÇELİK*, TİTCK President
Innovation in Pharmaceuticals: From Scientific Breakthrough to Regulatory Transformation
> Digital Transformation of eCTD and Regulatory Affairs, Dr. Pharm. Elif AVANER
> Clinical Trials of Biosimilar Products and Innovative Approaches, Pharm. Ömer ÇOBAN
Digital Transformation in Regulatory Affairs: Shaping the Future of Regulation with People, Data, and AI, from Application to Decision
Moderator: Pharm. Derya DÖNMEZ, Regulatory Affairs Director at Sanofi Turkey
> Salih GÜREŞ, TC Health General Manager
> Umut AĞYÜZ, Digital Project Manager at the Ministry of Health
> Karen PHILIPPE*, Generative AI (GenAI) Regulatory Lead at Sanofi
Innovation in Vaccine Development and Manufacturing: Advantages and Challenges
> Dr. Özde Tırna, Eurasia Regional Medical Director, Sanofi Vaccines
The Future of National and International Pharmaceutical Markets: Potential Challenges and Solution Scenarios
Moderator: Sami TÜRKOĞLU, MD, TISD General Secretary
>Umit DERELI, Secretary General of AIFD
>Savas MALKOC, Secretary General of IEIS
>Sami TURKOGLU, MD, Secretary General of TISD
The Biotechnology Journey Shaping the Future
> Dr. Mutlu YEŞİLBOĞAZ, Amgen Türkiye Senior Medical Director
Current Applications of Personalized Medicine via Genomic Approaches
> Prof. Fatma Duygu ÖZEL DEMİRALP, President of Biotechnology Institute of Türkiye
> Assoc. Prof. Rizvan İMAMOĞLU, Researcher, Biotechnology Institute of Türkiye
Turkey’s Position and Future in the Global Biopharmaceutical Sector
> Dr. Hasan Ersin ZEYTİN, CEO of Yerlika
Novel Biotechnological Molecules and Production Technologies in National and International Markets
Moderator: Prof. Ali Demir SEZER
> Dr. Bilgen DÖLEK UÇAROL, Market Access, Health Policy & Corporate Affairs Director at Amgen Turkey
> Dr. Hasan Ersin ZEYTİN, CEO of YERLIKA
> Mine ÖMEROĞLU, İLKO İlaç Strategy and Business Developement Director
> Levent GÜNDEĞER, EEMEA Regional Director, CYTIVA Türkiye
The Pharmaceutical Technologies and API Symposium brings together academia, public institutions, and industry to address the full value chain of pharmaceuticals—from R&D to manufacturing—through a multidisciplinary perspective encompassing biotechnology, artificial intelligence, GMP processes, and clinical research, fostering knowledge exchange and collaboration.
> Prof. Ali Demir SEZER, Marmara University Faculty of Pharmaceuticals
> Prof. Ali Osman KILIÇ, Izmir Biomedicine And Genome Center (IBG)
> Dr. Hasan Selçuk SELEK, TUBITAK TEYDEB
TUBITAK Supports on Academical Projects and Private Sector
> Dr. Pharm. Meltem KAPLAN DOĞAN, Senior Scientific Programs Expert
Information Presentation on TEYDEB Private Sector Grants
> Melike Nur Hilal YARDIMCI, Scientific Programs Expert
Information Presentation on ARDEB Academic Grants
The Importance of Innovation in Industry-Academia Collaboration
> Ümit FIRAT, Director of Biotechnology Innovation and Industrial Cooperations, Atlas University
> Dr. Hakan KARALÖK, Advisor to the Chairman of the Board of Trustees Atlas University
Localization in Pharmaceuticals Indutry: Human Resources, Infrastructure, and Ecosystem Model
Moderator: M. Adil KAYA, Atabay İlaç ve Kimya Sanayi
> Prof. Mutlu AYTEMİR, Hacettepe University The Dean of Faculty of Pharmaceuticals
> Berk ÖZDEMİR, CEO of OMEGA Research
> Erdinç YAŞRİN, Chairman of TİYSAT
Biopharmaceutical Development Processes
Moderator: Prof. Ali Osman KILIÇ, İzmir Biomedicine And Genome Center
> Dr. Sibel KALYONCU - Dr. Ayça Z. KUYUCU
From Discovery to Candidate Product: The Biopharmaceutical Development Journey
> Specialist Pharm. Ayşegül DEMİRTAŞ
Preclinical Pharmacology and Toxicology Studies for Biopharmaceutical Candidates
Regulation and Novel Approaches in Cell and Gene Therapy
> Prof. Tunç AKKOÇ, Marmara Univ. School of Medicine, Dept. of Basic Medical Sciences
> Prof. Fatih Süheyl EZGÜ, Gazi Univ. School of Medicine
> Dr. Tolga AKKOÇ, Marmara University
Clinical Trials in Biopharmaceuticals
Moderator: Prof. Yağız ÜRESİN, Istanbul University
> Pharm. Ömer ÇOBAN, TITCK Department of Clinical Trials
> Umut MÜREN, Clinical Research Unit Director, Sanofi Turkey and Middle East
> Assoc. Prof. Dr. Mustafa ÜNAL, Head of Clinical Research Department, TUSEB
> Assoc. Prof. Dr. Onur Saydam, Medical Director, Pfizer Türkiye
> Gülay Gökçe ÖZEL, Director of Clinical Research Turkey, Thermo Fisher Scientific
Open to invited participants only.
Table 1: Clinical Research
Moderator: Prof. Ali Yağız ÜRESİN, İstanbul University
Table 2: Regulatory Affairs
Moderator: Prof. Ali Demir SEZER, Marmara University
Table 3: Pharmacoeconomics
Moderator: Prof. Zafer ÇALIŞKAN, Hacettepe University
Table 4: Audit
Moderator: Haşim SOLMAZ, Lighthouse Worldwide Solutions
Searching for the Future Together in the Pharmaceutical Industry
> Hüseyin ÇELİK, TITCK President
> Prof. Ali Demir Sezer
> Prof. Ali Yağız Üresin
> Prof. Zafer Çalışkan
> Haşim Solmaz
BIOEXPO 2026 Declaration and Next Year Commitments Announcement
Moderator: Prof. Ali Demir SEZER
Kamu Otoritesi:
Hüseyin ÇELİK, TITCK President
TITCK Authorities
Sektör Temsilcileri:
Savaş MALKOÇ, IEIS Secretary General
Dr. Sami TÜRKOĞLU, TISD Secretary General
Dr. Ümit DERELI, AIFD Secretary General